studies have found that depression is accompanied with decreased levels of BDNF and pCREB in the hippocampus, whereas chronic antidepressant treatments reverse these molecular changes. [13] [14] [15] Heterogeneous BDNF-knockout mice display significantly higher immobility in the forced swimming test (FST) and tail suspension test (TST) than WT mice, while the overexpression of hippocampal BDNF produces antidepressant-like effects in mice. [16] [17] [18] [19] All these studies indicate the critical role of BDNF in depression and antidepressant responses.
Tetrahydroxystilbene glucoside (TSG) is the main active ingredient of Polygonum multiflorum. Recently, more and more pharmacologic effects of TSG on the brain have been reporting, including the protective effects against Parkinson's disease and cerebral ischemia/ reperfusion, improvement of learning and memory, and so on. [20] [21] [22] Chen et al. showed that chronic TSG administration obviously promoted the expression of BDNF in the hippocampus. 23 Lin et al. found that TSG significantly increased the release of BDNF in astroglia. 24 Here, we speculated that TSG may have antidepressant-like effects.
In this study, we investigated this speculation based on three observations: first, a variety of depression tests were performed to assay the antidepressant effects of TSG on mice behavior. Second, we examined the effects of TSG on the hippocampal BDNF signaling pathway and neurogenesis in CSDS-stressed mice. Moreover, the pharmacological inhibitors and lentiviral-shRNA were used.
| MATERIALS AND METHODS

| Animals
The 8-week-old male C57BL/6J mice were bought from the Experimental Animal Center of Nantong University (China) and housed under the standard conditions (12-h light/dark cycle; temperature 24±1°C; relative humidity 55±10%) for 1 week. All the behavioral experiments were performed in the day and conducted in compliance with the Guide for the Care and Use of Laboratory Animals (8th edition,
Institute of Laboratory Animal Resources on Life Sciences, National
Research Council, National Academy of Sciences, Washington DC).
| Materials
TSG (purity >98%), fluoxetine, and p-chlorophenylalanine methyl ester (PCPA) were supplied by Sigma (St. Louis, MO, USA). K252a was bought from Alomone Laboratories (Jerusalem, Israel). TSG, fluoxetine, and PCPA were dissolved in normal saline, with K252a dissolved in 1% DMSO in normal saline. The dosages of TSG, fluoxetine, PCPA, and K252a were chosen based on previous reports, [25] [26] [27] [28] and these drugs were intraperitoneally (ip) injected in a volume of 10 mL/kg.
| Forced swim test
This was performed according to our previous reports. 25, 26 The test was performed using plastic cylinders (diameter 20 cm, height 45 cm)
supplied by Xinruan Information Technology Co., Ltd (Shanghai, China).
Before the test, the cylinders were filled with 15 cm of water (25±1°C).
The C57BL/6J mice were individually placed in the cylinders, and the test time was 6 minutes. For each trial, the water was replaced.
| Tail suspension test
This was performed according to our previous reports. 25, 26 The test C57BL/6J mice were individually suspended 60 cm above the floor with their immobility time recorded during a test period of 6 minutes.
Adhesive tape was used to fasten the mice (1 cm from the tail tip).
| Open-field test
The open-field test was also carried out as we previously described. 25, 26 An open-field apparatus (100×100×40 cm) containing 25 equal squares (5×5 cm) was used. The test C57BL/6J mice were individually placed in the central square, and the test period lasted for 5 minutes under dim light condition. For each trial, the apparatus was cleaned.
| CSDS, social interaction, and sucrose preference experiments
The chronic social defeat stress procedure, social interaction test, and sucrose preference test were also performed as we previously described. 25, 26 Briefly, the CSDS stress period lasted for 10 days. During each day, the experimental C57BL/6J mice were exposed to different aggressive CD1 mice for 10 minutes, and then, plastic dividers containing holes were used to separate them. After the stress, the defeated mice were received daily treatment of vehicle/TSG/fluoxetine for 14 days. Then, the social interaction test containing two trials ("target absent" trial, "target present" trial) was performed. Each trial lasted for 5 minutes, and the duration time in the interaction zone spent by the test mice was individually recorded. Last, the sucrose preference test lasting for 4 days was carried out. During the first 2 days, the test mice were individually exposed to two bottles containing pure water and 1% sucrose solution, respectively. On the 3rd day, both the food and two bottles were deprived for 18 hours. On the 4th days, the test lasted for 6 hours, with the two bottles weighed before and after the test period. Drug treatments were not given during the testing days.
| Intrahippocampal injection of lentiviral expressed short hairpin RNA (shRNA)
This was done as we previously did with modifications. 29 The C57BL/6J mice were anaesthetized with 0.5% pentobarbital sodium and fixed in stereotaxic frames. The scalp was cut, and the skull was exposed using 75% alcohol and 1% H 2 O 2 . The 5-μL microsyringes were used to deliver the lentivirus. After making a small drill hole on the skull, the microsyringes were positioned at the following coordinates:
AP=−2.3 mm, ML=±1.5 mm, DV=+1.4 mm (CA1), and 1.8 mm (DG).
The injections of the scrambled/TrkB-shRNA lentiviral constructs were performed bilaterally in two different places (CA1 and DG) at a rate of 0.5 μL/min (final volume, 2 μL/side), and the microsyringes were maintained in place for 4 minutes to limit reflux along the injection track. The incision was sutured, and the mice were allowed to recover for 3 days before the experiments started.
The self-inactivating lentivirus vectors containing a CMV-driven EGFP reporter and a U6 promoter upstream of cloning restriction sites (HpaI and XhoI) were provided by Shanghai Genechem Co., Ltd.
(Shanghai, China) and used to allow the introduction of oligonucleotides encoding short hairpin RNAs (shRNAs). The TrkB-shRNA sequence was 5′-GCAACCTGCGGCACATAAA-3′, while the control scrambled-shRNA sequence was 5′-TTCTCCGAACGTGTCACGT-3′.
The titers were adjusted to 5×10 9 TU/mL in this study.
| Western blot analysis
The Western blotting method was performed according to our previous reports and other reports. 25, 26, [30] [31] [32] [33] [34] [35] Briefly, the test mice were sacrificed 
| Immunohistochemical analysis
The immunofluorescence assay for examining hippocampal neurogenesis was also carried out according to our previous reports and other reports. 26, 29, 36, 37 Briefly, the test mice were anaesthetized and perfused transcardially using 4% paraformaldehyde in 0.01 mol/L phosphate buffer (PBS). The brains were dissected, postfixed, and dehydrated.
Then, 25 μm hippocampal slices were collected using a freezing microtome (Leica, Wetzlar, Germany). 
| Statistical analysis
The data are shown as means±SEM. The SPSS 13.0 software (IBM, Armonk, NY, USA) was used to perform the analysis. The comparisons between groups were performed using one-way analysis of variance 
| RESULTS
| TSG produces antidepressant-like effects in the FST and TST without affecting the locomotor activity
The effects of TSG (15, To investigate the lasting changes in the hippocampus, the downstream molecules of BDNF signaling were also detected. In addition to BDNF, CSDS significantly reduced the expression of hippocampal pTrkB, p-ERK1/2, p-AKT, and p-CREB (n=5, P<.01 vs vehicle; Figure 3 ), while these molecular changes were fully reversed by TSG (n=5, P<.01 vs CSDS+vehicle; Figure 3 ). In contrast, the total TrkB, ERK1/2, AKT, and CREB levels were unchanged among all the groups.
| The decreased hippocampal neurogenesis in the CSDS-stressed mice is restored by TSG
Depression is always accompanied with decreased hippocampal neurogenesis, while chronic antidepressant treatments (like fluoxetine) could up-regulate the hippocampal neurogenesis. 38 ,39 Therefore, we examined whether TSG can prevent the CSDS-induced effects on neurogenesis. As we previously did, the hippocampal doublecortin (DCX)
labeling was used to assay neuronal proliferation. As shown in Fig. S1A , Fig. S1B ).
| Blockade of the hippocampal BDNF signaling abolishes the antidepressant effects of TSG in mice
The above results show that TSG may exhibit antidepressant effects via activating the BDNF system in the hippocampus. To confirm this speculation, the pharmacological inhibitor of TrkB, K252a, was used to block the BDNF system. 40, 41 The C57BL/6J mice were first injected with K252a (25 μg/kg) and then injected with TSG (60 mg/kg), and followed by the FST or TST. It was found that K252a alone had no effects on the immobility of mice in the FST or TST. In contrast, when used in combination with TSG, K252a attenuated the effects of TSG in both the FST (n=10, Figure 4A ) and TST (n=10, Figure 4B ). Next, the CSDS-stressed mice were co-injected with TSG and K252a for 14 days. Similarly, we found that K252a prevented the antidepressant effects of TSG on the social interaction (n=10, Figure 4D ) and sucrose preference (n=10, Figure 4C ) of mice.
Furthermore, LV-TrkB-shRNA-EGFP was used to knockdown the expression of TrkB. LV-TrkB-shRNA-EGFP was injected into the hippocampus. After 14 days, the expression of lentivirus was stable ( Figure 5A ), and our Western blot analysis confirmed the silencing effects of TrkB-shRNA. After that, different tests were performed. We found that TrkB-shRNA pretreatment significantly prevented the antidepressant effects of TSG (60 mg/kg) in the FST (n=10, Figure 5C) and TST (n=10, Figure 5D ). Also, TrkB-shRNA fully blocked the effects of TSG on the CSDS-stressed mice in both the social interaction test (n=10, Figure 5F ) and sucrose preference test (n=10, Figure 5E ).
Moreover, Western blotting and immunohistochemical studies showed that the restoring effects of TSG on the hippocampal BDNF signaling pathway and neurogenesis were all abolished by TrkB-shRNA ( Figure 6 , Fig. S2 and S3 ). Taken together, activation of the hippocampal BDNF signaling cascade is required for the antidepressant effects of TSG.
| Blockade of the serotonin system does not affect the antidepressant effects of TSG in mice
Considering other hypotheses for the pathophysiology of depression, especially the monoamine hypothesis, 5, 8 we therefore used the tryptophan hydroxylase inhibitor PCPA to deplete serotonin.
42,43
The C57BL/6J mice were first injected with PCPA (300 mg/kg) and then injected with TSG (60 mg/kg), and followed by the FST or TST.
However, PCPA pretreatment produced no influence on the effects of TSG in the FST (n=10, Fig. S4A ) or TST (n=10, Fig. S4B ). Then, the CSDS-stressed mice were co-injected with TSG and PCPA for 14 days, The comparisons were made by two-way ANOVA followed by post hoc Bonferroni's test and it was found that PCPA did not block the reversing effects of TSG on the stressed mice in the social interaction test (n=10, Fig. S4D ) or sucrose preference test (n=10, Fig. S4C ).
| DISCUSSION
From previous studies, we learn that TSG has some interesting pharmacological properties such as enhancing the expressions of BDNF in the hippocampus, protecting against oxidative stress, and enhancing learning and memory. 22, 24, 44 Importantly, these functions of TSG are similar to antidepressants, as depression is always accompanied with increased hippocampal neuronal death, decreased release of neurotrophic factors, and also decreased learning and memory. [45] [46] [47] Thus,
we have a speculation that TSG may possess antidepressant-like effects. In this study, our hypothesis was first confirmed in the FST and TST, as the two tests are the most commonly used methods to detect potential antidepressant activities. 47 Our data revealed that TSG had properties common to classical antidepressant (fluoxetine) in the FST and TST, which were not due to the stimulation of locomotion. Next, showing that TSG not only produces positive effects on neuronal growth and survival, but also has neuroprotective effects in a mouse model of Parkinson's disease. 20, 48 To explore the antidepressant mechanisms of TSG, we finally selected BDNF in the study, as (i) BDNF is closely involved in depression and hippocampal neurogenesis 8, 49 ; (ii) a previous study showed that TSG promotes hippocampal memory and synaptic plasticity via promoting the expression of BDNF in the hippocampus. 23 (iii) TSG also activates the phosphorylation of ERK1/2, AKT, and CREB, several key downstream signaling pathways of BDNF. 23, 50 In this study, chronic TSG treatment significantly reversed the CSDSinduced decrease of BDNF, pTrkB, pERK1/2, pAKT, and pCREB in the Quantitative analysis indicated that TrkBshRNA infusion prevented the TSG-induced promotion of hippocampal BDNF, pTrkB, pERK1/2, pAKT, and pCREB expression in stressed mice. The CSDS+TSG+TrkB-shRNA mice displayed significantly lower BDNF, pTrkB, pERK1/2, pAKT, and pCREB levels in the hippocampus than the CSDS+TSG mice. The data are expressed as means±SEM (n=5); **P<.01 vs vehicle; ##P<.01 vs CSDS+vehicle. The comparisons were made by two-way ANOVA followed by post hoc Bonferroni's test
In conclusion, our results provide a new insight into understanding the pharmacological effects of TSG. Due to a prevalent belief that "natural is better," a significant amount of public interests in antidepressants development have focused on herbal medicine, like ginsenosides, St John's wort, and so on. 57, 58 We believe that this study sheds light on the development of new antidepressants with higher efficacy and fewer side effects.
